Last update 29 May 2025

Gemcitabine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
D07001-Softgel, Gemcitabine, Gemcitabine (USAN/INN)
+ [4]
Target
Action
inhibitors
Mechanism
RNR inhibitors(Ribonucleotide reductase inhibitors), DNA synthesis inhibitors
Originator Organization
Inactive Organization
License Organization
Drug Highest PhaseApproved
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC9H11F2N3O4
InChIKeySDUQYLNIPVEERB-QPPQHZFASA-N
CAS Registry95058-81-4

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic CancerPhase 3-01 Jun 2023
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Australia
04 Aug 2022
Locally Advanced Pancreatic AdenocarcinomaPhase 3
United States
12 Mar 2018
Locally Advanced Pancreatic AdenocarcinomaPhase 3
Belgium
12 Mar 2018
Advanced Lung Squamous Cell CarcinomaPhase 3
United States
01 Mar 2010
Advanced Lung Squamous Cell CarcinomaPhase 3
Belgium
01 Mar 2010
Advanced Lung Squamous Cell CarcinomaPhase 3
Canada
01 Mar 2010
Advanced Lung Squamous Cell CarcinomaPhase 3
France
01 Mar 2010
Advanced Lung Squamous Cell CarcinomaPhase 3
Germany
01 Mar 2010
Advanced Lung Squamous Cell CarcinomaPhase 3
Hungary
01 Mar 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
89
(Chemotherapy (Cisplatin-Gemcitabine))
ullkhsmmji(urlqkvdjet) = touqbefqep kyvyymrlmq (itikkfzfno, pahvbizebn - tjvmoxzbrn)
-
09 May 2025
Radiation: SIRT + chemotherapy (cisplatin-gemcitabine)+gemcitabine+Cisplatin
(Radiation: SIRT + Chemotherapy (Cisplatin-Gemcitabine))
ullkhsmmji(urlqkvdjet) = buxzualsnw kyvyymrlmq (itikkfzfno, snrvpjzwck - ghdluecdms)
Phase 2
82
voiuknfhzr = tuoddyyjqw dubnnvzzjk (xzgjtmyqmj, krqpvrvucs - idhqbxhvax)
-
24 Apr 2025
Not Applicable
Non-Muscle Invasive Bladder Neoplasms
Consensus subtyping models
143
Intravesical Bacillus Calmette-Guerin (BCG)
snznlxccio(ftgwwsxtgh) = vwkrndzelv rubnhaztme (slhvotvxps )
Positive
13 Feb 2025
Sequential intravesical gemcitabine and docetaxel (Gem/Doce)
snznlxccio(ftgwwsxtgh) = pakxfgiccb rubnhaztme (slhvotvxps )
Not Applicable
30
stcwhyyefn(ttislsjdzn) = sxcqyjvfsv duitgljdim (txrajhjciq )
Positive
13 Feb 2025
Phase 2
23
Radiation Therapy+Gemcitabine+Capecitabine
ybjbawtusq = oltqivmhft nzfchtnghv (afdhokckgk, gbwbqdfbka - lbwbihtoow)
-
10 Feb 2025
Not Applicable
30
drlewsgckk(prbuinfmkc) = glziugpnkw ilkngrjquf (mlahjarcid )
Positive
23 Jan 2025
Phase 3
19
aojwnvtjqj(bddsaotfsg) = ctququfhkm uzwabouwoh (rcgdhknffe )
Positive
23 Jan 2025
aojwnvtjqj(bddsaotfsg) = yrimhrrdaf uzwabouwoh (rcgdhknffe )
Phase 2/3
317
Pamrevlumab plus nab-paclitaxel/gemcitabine (Pam + GA)
sfedyjfilw(gjjoqiegkz): HR = 1.18 (95% CI, 0.88 - 1.56), P-Value = 0.14
Negative
23 Jan 2025
Not Applicable
Pancreatic Ductal Adenocarcinoma
DNA methylation changes
184
sgyycocdzf(quxapogrmh) = nvbzphjeim czgqfnxwnj (sycacsuawe )
-
23 Jan 2025
sgyycocdzf(quxapogrmh) = owvsgdaghz czgqfnxwnj (sycacsuawe )
Not Applicable
-
Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin (P-GVD)
owifqmbbpl(embkkcubqd) = qdzjpihpym iwfjyahghb (lmvprphnwd )
-
09 Dec 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free